Drugs used in Asthma and COPD Flashcards Preview

CPR Exam 2 > Drugs used in Asthma and COPD > Flashcards

Flashcards in Drugs used in Asthma and COPD Deck (68)
Loading flashcards...
1
Q

What are some precipitating/aggravating factors of asthma?

A
Viral Respiratory Infections
Exercise
Endocrine factors
Drugs: Aspirin, Beta-blockers
Weather changes: cold air
Allergens
Emotional expression: anger, laughing
Food additives: Sulfites
Environmental changes
Exposure to irritants & occupational chemicals
2
Q

What are some comorbid conditions of asthma?

A
Allergic/ Non-allergic Rhinitis
Chronic sinusitis
GERD
Obesity
Obstructive sleep apnea
Other resp conditions
Other allergic conditions
Respiratory infections
COPD
Smoking nicotine dependence
Hyperventilation
Upper airway dysfunction 
Hormonal changes
3
Q

Describe the components of asthma management.

A

Routine monitoring of Sx and lung function

Pt education to create partnership b/w clinician & Pt

Controlling environmental factors (trigger factors) & comorbid conditions that contribute to asthma severity

Pharmacologic therapy

4
Q

What are the goals of asthma management?

A

1) Reduction in impairment

2) Reduction of risk

5
Q

What are the 2 drug categories used for Asthma tx?

A

Anti-inflammatory drugs

Bronchodilators

6
Q

Under Anti-inflammatory drugs, what are the subcategories?

A

Hormone-containing (corticosteroids)

  • ICS
  • Oral

Antibodies

Non-hormone-containing leukotriene receptor modifiers

  • lipoxygenase inhibitors
  • Receptor blockers
7
Q

Under bronchodilators, what are the subcategories?

A

Beta-2 agonists (very effective)

  • SABA (short-acting)
  • LABA (long-acting)

Anti-cholinergic drugs

Methylxanthines

8
Q

Describe the MOA of bronchodilator therapy. Include each subcategory of bronchodilators.

A

Beta agonists = stimulates AC increasing cAMP

Methylxanthine (theophylline):

  • inhibits PDE increasing cAMP
  • inhibits adenosine which causes bronchoconstriction

Muscarinic antagonists = inhibits Ach which causes bronchoconstriction

9
Q

What drug category is most widely used in tx of Asthma and COPD?

A

B2 receptor agonists

10
Q

What is the primary action of B2-agonists?

A

Relax airway smooth muscle cells of all airways

11
Q

Name the B2-agonist drugs. Elaborate which are SABA vs. LABA.

A
SABA:
Albuterol
Terbutaline
Metaproterenol
Pirbuterol
Levalbuterol
LABA:
Fomoterol 
Salmeterol 
Indacaterol and Vilanterol
Olodaterol
12
Q

Describe the indications, adverse effects, & contraindications of Albuterol.

A

Indications = asthma, acute bronchitis, COPD, bronchiolitis

Adverse effects = HA, dizziness, insomnia, dry mouth, cough

Contraindications = Paradoxical bronchospasm, deterioration of Asthma, CV effects, immediate hypersensitivity rxns

13
Q

Describe the indications, adverse effects, & contraindications of terbutaline. What is special about this drug?

A

Only B2 drug available by subcutaneous injection (not recommended for pts with sulfur allergy b/c it is a terbutaline sulfate injection)

Indications = Tx/prophylaxis of bronchospasm assoc with asthma, bronchitis, and emphysema in pts 12+

Adverse effects = HA, nausea, tachycardia, palpitation

Contra = Not recommended as medication for tocolysis (preterm labor)

14
Q

Describe the indications & contraindications of Metaproterenol.

A

Indications = Bronchial asthma and for reversible bronchospasm which may occur in assoc with bronchitis and COPD

Contra = Produce signif cardiovascular effects in some pts. Can produce paradoxical bronchospasm

15
Q

Describe the indications & contraindications of Pirbuterol.

A

Indications = Prevention and reversal of bronchospasm in pts 12+ with reversible bronchospasm including asthma. May be used with or without concurrent theophylline corticosteroid therapy

Contra = Cardiovascular effects

16
Q

Describe the indications & contraindications of Levalbuterol.

A

Indications = Tx or prevention of bronchospasm in pts 4+ with reversible obstructive airway dz

Contra = Life-threatening paradoxical bronchospasm

Less CV effects than albuterol

17
Q

Describe the indications and contraindications of Fomoterol.

A

Indications = Tx of ASTHMA in pt >5 YO as an ADD-ON to long-term asthma control medication such as inhaled corticosteroid

Maintenance Tx of bronchoconstriction in pts with COPD

Contra = In asthma, don’t use w/o concomitant use of long term asthma control meds such as inhaled corticosteroid.
Use of LABAs increases risk of asthma related death and hospitalizations

18
Q

What do you absolutely need to remember about Fomoterol?

A

Prescribe for asthma ONLY as concomitant therapy with a long-term control med such as inhaled corticosteroid

19
Q

Describe the indications of Salmeterol.

A

Tx of asthma in pts aged 4+

Prevention of EXERCISE-INDUCED bronchospasm in pts 4+

Maintenance Tx of bronchospasm assoc with COPD

20
Q

Describe the indications of Indacaterol and Vilanterol.

A

Used to TX breathing probs caused by COPD, including chronic bronchitis and emphysema

21
Q

Describe the indications of Olodaterol.

A

Used in long-term, once-daily maintenance bronchodilator tx of airflow obstruction in pts with COPD, including chronic bronchitis and emphysema

22
Q

When should LABAs be used?

A

In concomitant use of a long term asthma control medication such as inhaled corticosteroid

23
Q

What do you prescribe a pt with mild intermittent asthma?

A

Short-acting B2-agonist PRN

24
Q

What do you prescribe a pt with mild persistent asthma?

A

SABA prn + ICS low dose

25
Q

What do you prescribe a pt with moderate persistent asthma?

A

SABA prn + ICS low dose + LABA

26
Q

What do you prescribe a pt with severe persistent asthma?

A

SABA prn + ICS high dose + LABA

27
Q

What do you prescribe a pt with very severe persistent asthma?

A

SABA prn + ICS high dose + LABA + OCS

28
Q

Name some combination inhalers (ICS + LABA).

A

Fluticasone + Salmeterol

Mometasone + Formoterol

Budesonide + Formoterol

29
Q

What is the MOA of anticholinergic drugs (muscarinic antagonists)?

A

Block Ach form binding to receptors on certain nerve cells

Inhibit parasympathetic nerve impulses

30
Q

What are the anticholinergic drugs most widely used in asthma/COPD?

A

Atropine
Ipratropium
Tiotropium
Aclindium

31
Q

Describe the indications and contraindication of Atropine.

A

Indication = blockade of severe or life-threatening muscarinic effects

TEMPORARY BLOCKADE

Contra = when recurrent use of atropine in pts with CAD, the total dose should be restricted to 2-3 mg to avoid detrimental effects of atropine-induced tachycardia

32
Q

Describe the indications of Ipratropium. Why can it be used for maintenance of tx unlike atropine?

A

Used as bronchodilator for maintenance tx of bronchospasm assoc with COPD, including chronic bronchitis and emphysema

Drug is potent atropine analog that is poorly absorbed after aerosol administration and is therefore relatively free of systemic atropine-like effects

33
Q

Describe the indications of Tiotropium.

A

Indicated for long-term, once-daily, maintenance tx of bronchospasm assoc with COPD and for reducing COPD exacerbations

34
Q

Describe the indications of Aclidinium.

A

Indicated for long-term maintenance tx of bronchospasm assoc with COPD, including chronic bronchitis and emphysema

35
Q

Name some methylxanthines.

A

Theophylline (most widely used drug)

Theobromine (chocolate)

Caffeine

36
Q

What are the 2 distinct actions theophylline has on the airways of pts with reversible obstruction?

A

1) Smooth muscle relaxation (bronchodilation)

2) Suppression of response of airways to stimuli (non-bronchodilator prophylactic effects)

37
Q

In which pts do you have to be cautious of using theophylline?

A

Due to increased risk of exacerbation, use extreme caution in pts w/ active peptic ulcer dz, seizure disorders, & cardiac arrhythmias

38
Q

What are the benefits of ICS therapy?

A

Most effective controllers of asthma

Most effective anti-inflammatory agents used in asthma therapy, reducing inflamm cell #s & their activation in airways

Reduce eosinophils in airways & sputum

Reduce #s of activate T-cells & surface mast cells in airway mucosa

39
Q

What is the major effect of corticosteroids?

A

Switch off transcription of multiple activated genes that encode inflammatory proteins

40
Q

How often are ICS prescribed?

A

Twice daily

Some may be effective once daily in mildly symptomatic pts.

41
Q

ICS rapidly improves SX of? Effective in preventing asthma SX such as?

A

Rapidly improves SX of asthma, & lung function improves over several days

Effective in preventing asthma SX, such as exercise induced asthma and nocturnal exacerbations

42
Q

Why is early treatment with ICS beneficial? What occurs with withdrawal of ICS?

A

Appears to prevent irreversible changes in airway functions that occurs with chronic asthma

Withdrawal of ICS results in slow deterioration of asthma control, indicating that they suppress inflammation and symptoms, but don’t cure underlying condition

43
Q

Name some inhaled corticosteroids.

A
Beclomethasone 
Budesonide 
Ciclesonide
Flunisolide
Fluticasone
Mometasone 
Triamcinolone
44
Q

Name oral and parenteral corticosteroid.

A

Prednisone

45
Q

Describe when Beclomethasone is used.

A

Prescribed as maintenance TX of asthma & as prophylactic therapy in pts 5+

Also used in tx of asthma in pts who require oral therapy to reduce or eliminate need for systemic corticosteroids

46
Q

When may Beclomethasone be a bad choice in treatment?

A

Care needed in pts who are transferred from systemically active corticosteroids to beclomethasone because deaths due to adrenal insufficiency have occurred in asthmatic pts during and after transfer form systemic corticosteroids to less systematically available ICS

After withdrawal from systemic corticosteroids, a number of months are required for recovery of hypothalamus-pituitary-adrenal (HPA) function

47
Q

Describe when and when not to use Budesonide.

A

Use for maintenance of tx of asthma as prophylactic therapy in adult and pediatric pts 6+ yo

Caution = drug shouldn’t be used where primary tx of status asthmaticus or other acute episodes of asthma where intensive measures are required. Severe hypersensitivity to milk proteins and any of the ingredients in Budesonide is contraindicated

48
Q

Describe when and when not to use Ciclesonide.

A

Prescribed as ICS indicated for maintenance of tx of asthma as prophylactic therapy in adult and adolescent pts 12+

Caution = Not indicated for relief of acute bronchospasm. Use not recommended in presence of candida albicans infection of mouth and pharynx, tuberculosis, fungal, bacterial, viral, or parasitic infection

49
Q

Describe when and when not to use Flunisolide.

A

Indicated in maintenance tx of asthma as prophylactic therapy in adult and peds pts 6+. Also for asthma pts requiring oral corticosteroid therapy, where adding Flunisolide therapy may reduce or eliminate need for oral corticosteroids

50
Q

Describe when and when not to use Fluticasone.

A

Maintenance tx of asthma as prophylactic therapy in pts 4+. Not indicated for relief of acute bronchospasm

Caution = candida albicans infection of mouth and pharynx may occur. Monitor. Advise pts to rinse mouth with water without swallowing after inhalation to reduce risk

51
Q

Describe when and when not to use Mometasone.

A

Maintenance of tx of asthma as prophylactic therapy in pts 4+

Caution = use of drug is contraindicated in pts with status asthmaticus or other episodes of asthma where intensive measures are required. Also, contraindicated in pts with hypersensitivity to milk proteins or any ingredients of drug.

52
Q

Describe when and when not to use Triamcinolone.

A

Indicated in maintenance tx of asthma as prophylactic therapy
Also for asthma pts who require systemic corticosteroid administration, where adding this agent may reduce or eliminate need for systemic corticosteroids

Not indicated for relief of acute bronchospasm

Caution = contra in primary tx of status asthmaticus or other acute episodes of asthma where intensive measure are required. Particular care needed in pts who are transferred from systemically active corticosteroids to triamcinolone b/c death due to adrenal insufficiency have occurred in asthmatic pts during and after transfer from systemic corticosteroids to aerosolized steroid therapy

53
Q

When are oral corticosteroids used? Are they likely to cause side effects?

A

Used in combo with SABA to treat moderate to severe asthma flare-ups

More likely to cause side effects than ICS

54
Q

Describe when and when not to use Prednisone.

A

Used as anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, GI, hematologic, ophthalmologic, nervous, renal, resp, rheumatologic, specific infectious dz or conditions and organ transplantation

Also used for Tx of certain endocrine conditions and for palliation of certain neoplastic conditions

Caution = may lead to HPA axis suppression. Monitor pts for Cushing’s and hyperglycemia with chronic use and taper doses gradually for withdrawal after chronic use

55
Q

Name the leukotriene receptor antagonists/lipoxygenase inhibitors.

A

Zafirlukast

Montelukast

56
Q

What are the characteristics of leukotriene receptor antagonists?

A

Selective reversible antagonists of CysLT1 receptors

Taken orally

Bronchodilators

Anti-inflammatory action

Less effective than ICS

Have glucocorticoids sparing effect (potentiate corticosteroid action)

57
Q

Name the Lipoxygenase inhibitor.

A

Zileuton

58
Q

What is the use for leukotriene antagonists?

A

Among most prescribed drugs for management of asthma, used both for treatment and prevention of acute asthmatic attacks

59
Q

What are the leukotriene mediated effects of asthma? What is the MOA of leukotriene antagonists?

A

Effects include airway edema, smooth muscle contraction, and altered cellular activity assoc with inflammatory process

Acts by binding cysteinyl leukotriene (CysTL) receptors and blocking activation and the subsequent inflammatory cascade which cause symptoms commonly assoc with asthma and allergic rhinitis

60
Q

Describe the characteristics of Montelukast.

A

Orally active compound with high affinity and selectivity to cysLT1 receptor

Inhibits physiologic actions of LTD4 at the cysLT1 receptor without any agonist activity

61
Q

Describe when and when not to use Montelukast.

A

Primarily prescribed to treat allergies and prevent asthma attacks

Contra = not indicated for use in reversal of bronchospasm in acute asthma attacks, including status asthmaticus
-therapy can be continued during acute exacerbations, but pts should have a SABA available

62
Q

Describe characteristics of and when/when not to use Zafirlukast.

A

Selective and competitive receptor antagonist of LTD4 and LTE4, components of slow reacting substance of anaphylaxis (SRSA)

Prescribed for prophylaxis and chronic treatment of asthma in adults and children 5+

Caution = hepatotoxicity, cases of life-threatening hepatic failure have been reported in pts treated with drug

63
Q

Describe characteristics of and when/when not to use Zileuton.

A

Inhibitor of 5-lipoxygenase and thus inhibits leukotriene formation

Used as prophylaxis and chronic tx of asthma in adults and children 12+
NOT used to treat an acute asthma attack

Caution = not recommended in cases where active liver dz or persistent hepatic function enzyme elevations are >3x upper limit of normal

64
Q

Name the monoclonal antibody drug used to treat asthma.

A

Omalizumab

65
Q

What are the actions of Omalizumab?

A

1) Binds to free IgE, decreasing cell-bound IgE
2) Decreases expression of high-affinity receptors (FCeRI on mast cells)
3) Decreases mediator release
4) Decreases allergic inflammation and prevents exacerbation of asthma and reduces sx

66
Q

Describe the indications of Omalizumab.

A

Anti-igE antibody indicated for moderate to severe persistent asthma in pts 6+ with positive skin test or in vitro reactivity to a perennial aeroallergen and sx that are inadequately controlled with inhaled corticosteroids

Also indicated in tx of chronic idiopathic urticaria in adults and 12+ who remain symptomatic despite H1 antihistamine tx

67
Q

Describe the contraindications of Omalizumab.

A

contra = anaphylaxis - administer only in healthcare setting prepared to manage anaphylaxis that can be life-threatening and observe pt for appropriate period of time after administration

68
Q

How do you treat pts who have an overlap between asthma and COPD sx?

A

Triple therapy with ICS, LABA, and LAMA